skip to main content

Chemistry, part 2

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > diazines > pyrimidines > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > diazines > pyrimidines > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > diazines > pyrimidines > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > n-glycosyl compound > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > n-glycosyl compound > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > glycosyl compound > n-glycosyl compound > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > organooxygen compound > oxacycle > oxolanes > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > nucleobase-containing molecular entity > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > pyrimidine nucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > n-glycosyl compound > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > n-glycosyl compound > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > glycosyl compound > n-glycosyl compound > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > organooxygen compound > oxacycle > oxolanes > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > pyrimidine deoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > n-glycosyl compound > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > n-glycosyl compound > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > glycosyl compound > n-glycosyl compound > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > organooxygen compound > oxacycle > oxolanes > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > deoxyribonucleoside > 2',3'-dideoxyribonucleoside > pyrimidine 2',3'-dideoxyribonucleoside > zalcitabine

اصطلاح مرجح

zalcitabine  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • 0

فرمول

  • C9H13N3O3

نقشی دارد

اینچی

  • InChI=1S/C9H13N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h3-4,6,8,13H,1-2,5H2,(H2,10,11,14)/t6-,8+/m0/s1

اینچی‌کی

  • WREGKURFCTUGRC-POYBYMJQSA-N

جرم

  • 211.21780

جرم تک‌ایزوتوپی

  • 211.09569

اسمایلٓ

  • Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1

زیرمجموعه

  • 3_STAR

مترادف دقیق

  • 2',3'-dideoxycytidine

مترادف مرتبط

  • 2',3'-Dideoxycytidine
  • 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one
  • DDC
  • DDCYD
  • Dideoxycytidine
  • zalcitabine

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:10101

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD